معرفی
Guoping Cai, MD, is a Professor in the Department of Pathology at Yale School of Medicine, where he also serves as Associate Director of Cytopathology. His clinical and research work spans cytopathology, thoracic pathology, and genitourinary pathology, with a strong emphasis on molecular diagnostics and cancer biomarker discovery. He is affiliated with the Yale Cancer Center and actively contributes to interdisciplinary programs in cancer signaling networks and pancreatic diseases.
- Department: Department of Pathology
- School: Yale School of Medicine
- University: Yale University
- Specialties: Cytopathology, Thoracic Pathology, Genitourinary Pathology
Dr. Cai's educational background includes an MD and MS from Wenzhou Medical College, followed by residency and fellowship training in Pathology and Laboratory Medicine at New York University Medical Center. He is board-certified in Anatomic and Clinical Pathology.
His research interests focus on improving diagnostic accuracy through fine needle aspiration biopsy, rapid on-site evaluation, and molecular testing. Key areas include lung, pancreatic, thyroid, and bladder cancers, where he investigates biomarkers with diagnostic, prognostic, and therapeutic implications. His work integrates clinical pathology with advanced molecular techniques and machine learning applications.
The recent publications reflect a strong trend in translational pathology, emphasizing the integration of cytology, histology, molecular data, and imaging to refine cancer diagnosis and prognosis. His work frequently explores immunomarkers, gene fusions, and algorithmic approaches to diagnostic challenges in cytopathology.
Scientific honors include:
- Honorary Master of Arts degree from Yale University (2020)
Dr. Cai is actively involved in clinical research, contributing as a sub-investigator in a trial on mechanisms of sensitivity and resistance to anti-cancer therapy in advanced lung cancer. While no formal advisees are listed, he collaborates extensively with researchers including Adebowale Adeniran, Minhua Wang, and Tong Sun. His laboratory and clinical work are supported by institutional resources at Yale and the Yale Cancer Center.